特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
940606

ワクチン受託製造の世界市場 (2020-2030年):弱毒性ワクチン・不活化ワクチン・フルオロキノロン・サブユニットワクチン・トキソイドワクチン

Vaccine Contract Manufacturing Market Forecast 2020-2030: Prospects for Attenuated Vaccine, Inactivated Vaccine, Fluoroquinolones, Subunit Vaccines, Toxoid Vaccines

出版日: | 発行: Visiongain Ltd | ページ情報: 英文 290 Pages | 納期: 即日から翌営業日

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=140.38円

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

ワクチン受託製造の世界市場 (2020-2030年):弱毒性ワクチン・不活化ワクチン・フルオロキノロン・サブユニットワクチン・トキソイドワクチン
出版日: 2020年04月08日
発行: Visiongain Ltd
ページ情報: 英文 290 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のワクチン受託製造の市場は2019年に22億4160万米ドルを記録し、2020年から2025年にかけては9.3%のCAGRで成長すると予想されています。

当レポートでは、世界のワクチン受託製造の市場を調査し、ワクチンの概要、技術・法規制などの動向、市場規模の推移・予測、ワクチンタイプ・ワークフロー・用途など各種区分別の内訳、地域・主要国別の詳細分析、市場への各種影響因子の分析、競合環境、主要企業プロファイルなどをまとめています。

第1章 レポート概要

第2章 イントロダクション

  • ワクチンの歴史
  • ワクチンの機能
  • ワクチンのタイプ
    • 弱毒性ワクチン
    • 不活化ワクチン
    • サブユニットワクチン
    • 治療ワクチン
  • ワクチン市場の台頭
  • 技術・規制の改善
  • ワクチン製造技術
  • ワクチン製造のための新しい基質
  • 成長要因
  • 成長抑制要因

第3章 ワクチン受託製造市場の予測

  • 市場概要
  • 製薬・バイオテクノロジー産業におけるアウトソーシング
  • 収益予測
  • 市場予測
  • 市場シェアの変化:タイプ別
  • 収益の推移・予測:弱毒化ワクチン
  • 収益の推移・予測:不活化ワクチン
  • 収益の推移・予測:フルオロキノロン
  • 収益の推移・予測:サブユニットワクチン
  • 収益の推移・予測:トキソイドワクチン
  • 収益の推移・予測:その他

第4章 ワクチン受託製造市場の予測:ワークフロー別

  • 市場概要
  • 収益予測:ワークフロー別
  • 市場シェアの変化:ワークフロー別
  • 下流処理
  • 上流処理

第5章 ワクチン受託製造市場の予測:用途別

  • 市場概要
  • 収益予測
  • 市場シェアの変化:用途別
  • 収益の推移・予測:小児用ワクチン
  • 収益の推移・予測:成人用ワクチン
  • 収益の推移・予測:インフルエンザワクチン
  • 収益の推移・予測:治療用ワクチン

第6章 主要国市場の予測

  • 市場シェア:地域別
  • 市場予測:地域別

第7章 北米市場の予測

  • 市場予測:ワクチンタイプ別
  • 市場予測:ワークフロー別
  • 市場予測:国別

第8章 欧州市場の予測

  • 市場予測:ワクチンタイプ別
  • 市場予測:ワークフロー別
  • 市場予測:国別

第9章 アジア太平洋市場の予測

  • 市場予測:ワクチンタイプ別
  • 市場予測:ワークフロー別
  • 市場予測:国別

第10章 ラテンアメリカ市場の予測

  • 市場予測:ワクチンタイプ別
  • 市場予測:ワークフロー別
  • 市場予測:国別

第11章 中東・アフリカ市場の予測

  • 市場予測:ワクチンタイプ別
  • 市場予測:ワークフロー別
  • 市場予測:国別

第12章 主要企業

  • LONZA
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • AbbVie
  • Baxter (Baxter BioPharma Solutions)
  • Catalent, Inc.
  • PRA Health Sciences
  • KBI Biopharma, Inc.
  • Charles River Laboratories
  • Boehringer Ingelheim
  • IDT Biologika GmbH
  • Meridian Life Science

第13章 定性分析

  • 産業動向
  • 市場の強み・弱み
  • 市場成長推進因子・阻害因子

第14章 総論

関連レポート

図表

List of Figures

  • Figure 1.1 Global Vaccine Contract Manufacturing Market Segmentation Overview
  • Figure 3.1 Vaccine Contract Manufacturing Market: Market Share (%) by Vaccine Type, 2019
  • Figure 3.2 Vaccine Contract Manufacturing Market: Market Share (%) by Class, 2020
  • Figure 3.3 Global Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 3.4 The Global Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2018
  • Figure 3.5 The Global Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2019
  • Figure 3.6 The Global Vaccine Contract Manufacturing Market Forecast by Vaccine Type: CAGR (%), 2020-2030
  • Figure 3.7 The Vaccine Contract Manufacturing Market Segments: Revenue* ($m) Forecast, 2018-2030
  • Figure 3.8 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2018
  • Figure 3.9 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2024
  • Figure 3.10 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2030
  • Figure 3.11 Global Attenuated Vaccine Market Forecast: Revenue ($ m), AGR (%), 2018- 2030
  • Figure 3.12 Global Inactivated Vaccine Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
  • Figure 3.13 Global Fluoroquinolones Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
  • Figure 3.14 Global Subunit Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
  • Figure 3.15 Global Toxoid Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
  • Figure 3.16 Others Drugs Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 4.1 Vaccine Contract Manufacturing Market: Market Share (%) by Workflow, 2019
  • Figure 4.2 Vaccine Contract Manufacturing Market: Market Share (%) by Class, 2020
  • Figure 4.3 The Global Vaccine Contract Manufacturing Market Forecast by Workflow, 2019
  • Figure 4.4 The Global Vaccine Contract Manufacturing Market Forecast by Workflow, 2020
  • Figure 4.5 The Global Vaccine Contract Manufacturing Market Forecast by Workflow: CAGR (%), 2020-2030
  • Figure 4.6 The Vaccine Contract Manufacturing Market Segments: Revenue* ($m) Forecast, 2018-2030
  • Figure 4.7 Global Vaccine Contract Manufacturing Market by Workflow: Market Share (%), 2019
  • Figure 4.8 Global Vaccine Contract Manufacturing Market by Workflow: Market Share (%), 2024
  • Figure 4.9 Global Vaccine Contract Manufacturing Market by Workflow: Market Share (%), 2030
  • Figure 4.10 Global Vaccine Contract Manufacturing (Downstream Processing) Market: Revenue* ($m) Forecasts by Segment,2018-2030
  • Figure 4.11 Global Vaccine Contract Manufacturing (Downstream Processing) Market: Market Share (%), 2019
  • Figure 4.12 Global Vaccine Contract Manufacturing (Downstream Processing) Market: Market Share (%), 2024
  • Figure 4.13 Global Vaccine Contract Manufacturing (Downstream Processing) Market: Market Share (%), 2030
  • Figure 4.14 Global Fill & Finish Operations Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 4.15 Global Analytical & QC studies Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 4.16 Global Packaging Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 4.17 Global Vaccine Contract Manufacturing (Upstream Processing) Market: Revenue* ($m) Forecasts by Segment,2018-2030
  • Figure 4.18 Global Vaccine Contract Manufacturing (Upstream Processing) Market: Market Share (%), 2019
  • Figure 4.19 Global Vaccine Contract Manufacturing (Upstream Processing) Market: Market Share (%), 2024
  • Figure 4.20 Global Vaccine Contract Manufacturing (Upstream Processing) Market: Market Share (%), 2030
  • Figure 4.21 Global Mammalian Expression Systems Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 4.22 Global Bacterial Expression Systems Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 4.23 Global Yeast Expression Systems Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 4.24 Global Baculovirus/Insect Expression Systems Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 4.25 Global Others Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 5.1 Vaccine Contract Manufacturing Market: Market Share (%) by Application, 2019
  • Figure 5.2 Vaccine Contract Manufacturing Market: Market Share (%) by Class, 2020
  • Figure 5.3 The Global Vaccine Contract Manufacturing Market Forecast by Application, 2018
  • Figure 5.4 The Global Vaccine Contract Manufacturing Market Forecast by Application, 2019
  • Figure 5.5 The Global Vaccine Contract Manufacturing Market Forecast by Application: CAGR (%), 2020-2030
  • Figure 5.6 The Vaccine Contract Manufacturing Market Segments: Revenue* ($m) Forecast, 2018-2030
  • Figure 5.7 Global Vaccine Contract Manufacturing Market by Application: Market Share (%), 2018
  • Figure 5.8 Global Vaccine Contract Manufacturing Market by Application: Market Share (%), 2024
  • Figure 5.9 Global Vaccine Contract Manufacturing Market by Application: Market Share (%), 2030
  • Figure 5.10 Global Paediatric Vaccines Market Forecast: Revenue ($ m), AGR (%), 2018- 2030
  • Figure 5.11 Global Adult Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
  • Figure 5.12 Global Influenza Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
  • Figure 5.13 Global Therapeutic Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
  • Figure 6.1 World Vaccine Contract Manufacturing Market: Revenues ($ m) by Region, 2018
  • Figure 6.2 World Vaccine Contract Manufacturing Market: Revenues ($ m) by Region, 2019
  • Figure 6.3 Global Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 6.4 World Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2019
  • Figure 6.5 World Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2024
  • Figure 6.6 World Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2030
  • Figure 7.1 North America Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 7.2 North America Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2019
  • Figure 7.3 North America Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2024
  • Figure 7.4 North America Vaccine Contract Manufacturing Market: Market Shares (%) by Regional Market, 2030
  • Figure 7.5 U.S. Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
  • Figure 7.6 Canada Vaccine Contract Manufacturing Market Forecast: Revenues($m), AGR (%), 2018-2030
  • Figure 8.1 Europe Vaccine Contract Manufacturing Market: Revenues ($m) by Country/Sub-region, 2019
  • Figure 8.2 Europe Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 8.3 Europe Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2018
  • Figure 8.4 Europe Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2024
  • Figure 8.5 Europe Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2030
  • Figure 8.6 Germany Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
  • Figure 8.7 France Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
  • Figure 8.8 U.K. Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
  • Figure 8.9 Italy Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
  • Figure 8.10 Spain Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
  • Figure 8.11 Rest of Europe Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
  • Figure 9.1 Asia Pacific Vaccine Contract Manufacturing Market: Revenues ($m) by Country/Sub-region, 2019
  • Figure 9.2 Asia Pacific Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 9.3 Asia Pacific Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2019
  • Figure 9.4 Asia Pacific Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2024
  • Figure 9.5 Asia Pacific Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2030
  • Figure 9.6 Japan Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
  • Figure 9.7 China Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
  • Figure 9.8 India Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
  • Figure 9.9 Rest of Asia Pacific Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
  • Figure 10.1 Latin America Vaccine Contract Manufacturing Market: Revenues ($m) by Country/Sub-region, 2019
  • Figure 10.2 Latin America Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 10.3 Latin America Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2019
  • Figure 10.4 Latin America Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2024
  • Figure 10.5 Latin America Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2030
  • Figure 10.6 Brazil Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
  • Figure 10.7 Mexico Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
  • Figure 10.8 Rest of Latin America Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
  • Figure 11.1 Middle East & Africa (MEA) Vaccine Contract Manufacturing Market: Revenues ($m) by Country/Sub-region, 2019
  • Figure 11.2 Middle East & Africa Vaccine Contract Manufacturing Market Forecast: Revenue ($ m), AGR (%), 2018-2030
  • Figure 11.3 Middle East & Africa Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2019
  • Figure 11.4 Middle East & Africa Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2024
  • Figure 11.5 Middle East & Africa Vaccine Contract Manufacturing Market: Market Shares (%) by Country, 2030
  • Figure 11.6 Saudi Arabia Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), 2018-2030
  • Figure 11.7 South Africa Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
  • Figure 11.8 Rest of Middle East & Africa Vaccine Contract Manufacturing Market Forecast: Revenues ($m), AGR (%), 2018-2030
  • Figure 12.1 : Lonza Revenue ($m), AGR (%), 2015-2019
  • Figure 12.2 Lonza: Business Segment Revenue Share (%), 2018
  • Figure 12.3 Pfizer, Inc.: Revenue ($m), AGR (%), 2014-2018
  • Figure 12.4 Pfizer, Inc.: Business Segment Revenue Share (%), 2018
  • Figure 12.5 Pfizer, Inc.: Region Revenue Share (%), 2018
  • Figure 12.6 Merck & Co, Inc.: Revenue ($m), AGR (%), 2015-2019
  • Figure 12.7 Merck & Co., Inc.: Business Segment Revenue Share (%), 2019
  • Figure 12.8 Merck & Co., Inc.: Region Revenue Share (%), 2019
  • Figure 12.9 AbbVie: Revenue ($m), AGR (%), 2015-2019
  • Figure 12.10 AbbVie: Business Segment Revenue Share (%), 2019
  • Figure 12.11 AbbVie: Region Revenue Share (%), 2019
  • Figure 12.12 Baxter: Revenue ($m), AGR (%), 2014-2018
  • Figure 12.13 Baxter: Business Segment Revenue Share (%), 2018
  • Figure 12.14 Baxter: Breakdown of Revenue (%) by Region, 2018
  • Figure 12.15 Catalent, Inc.: Revenue ($m), AGR (%), 2015-2019
  • Figure 12.16 Catalent, Inc.: Business Segment Revenue Share (%), 2019
  • Figure 12.17 Catalent, Inc.: Reporting Segment Revenue Share (%), 2019
  • Figure 12.18 Catalent, Inc.: Breakdown of Revenue (%) by Region, 2019
  • Figure 12.19 PRA Health Sciences, Inc.: Revenue ($m), AGR (%), 2015-2019
  • Figure 12.20 PRA Health Sciences, Inc.: Business Segment Revenue Share (%), 2019
  • Figure 12.21 PRA Health Sciences, Inc.: Breakdown of Revenue (%) by Region, 2019
  • Figure 12.22 Charles River Laboratories: Revenue ($m), AGR (%), 2015-2019
  • Figure 12.23 Charles River Laboratories: Business Segment Revenue Share (%), 2019
  • Figure 12.24 Charles River Laboratories: Breakdown of Revenue (%) by Region, 2019
  • Figure 12.25 Charles River Laboratories: Breakdown of Revenue (%) by Region, 2019
  • Figure 12.26 Boehringer Ingelheim: Revenue ($m), AGR (%), 2014-2018
  • Figure 12.27 Boehringer Ingelheim: Business Segment Revenue Share (%), 2019
  • Figure 12.28 Boehringer Ingelheim: Breakdown of Revenue (%) by Region, 2019
  • Figure 12.29 Meridian Life Science: Revenue ($m), AGR (%), 2015-2019
  • Figure 12.30 Meridian Life Science: Business Segment Revenue Share (%), 2019
  • Figure 12.31 Meridian Life Science: Breakdown of Revenue (%) by Region, 2019
  • Figure 14.1 Vaccine Contact Manufacturing Market: Comparison of Revenue ($m Forecasts for Total Market* and Market for Vaccine Contract Manufacturing Indication, 2018-2030
  • Figure 14.2 Global Vaccine Contract Manufacturing Market Forecast: Revenue ($m) 2018, 2024, and 2030
  • Figure 14.3 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2018
  • Figure 14.4 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2024
  • Figure 14.5 Global Vaccine Contract Manufacturing Market by Vaccine Type: Market Share (%), 2030
  • Figure 14.6 The Global Vaccine Contract Manufacturing Market Forecast by Region: Revenue (US$m), 2018, 2024, and 2030

List of Tables

  • Table 2.1 Timeline of Key Events in Vaccine Development, c.1000 AD -- Present
  • Table 3.1 Vaccine Contract Manufacturing Market by Vaccine Type, 2020
  • Table 3.2 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 3.3 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 3.4 Global Vaccine Contract Manufacturing Market by Vaccine Type: CAGR (%), 2020-2024, 2024-2030, 2020-2030
  • Table 3.5 Global Attenuated Vaccine Market: Revenue* ($m), AGR (%) and CAGR (%), 2018-2030
  • Table 3.6 Global Inactivated Vaccine Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
  • Table 3.7 Global Fluoroquinolones Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 3.8 Global Subunit Vaccines Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 3.9 Global Toxoid Vaccines Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 3.10 Global Others Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018- 2030
  • Table 4.1 Vaccine Contract Manufacturing Market by Workflow, 2020
  • Table 4.2 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 4.3 Global Vaccine Contract Manufacturing Market by Workflow: CAGR (%), 2020- 2024, 2024-2030, 2020-2030
  • Table 4.4 Global Vaccine Contract Manufacturing (Downstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 4.5 Global Fill & Finish Operations Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 4.6 Global Analytical & QC studies Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 4.7 Global Packaging Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 4.8 Global Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 4.9 Global Mammalian Expression Systems Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 4.10 Global Bacterial Expression Systems Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 4.11 Global Yeast Expression Systems Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 4.12 Global Baculovirus/Insect Expression Systems Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 4.13 Global Others Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018- 2030
  • Table 5.1 Vaccine Contract Manufacturing Market by Application, 2020
  • Table 5.2 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 5.3 Global Vaccine Contract Manufacturing Market by Application: CAGR (%), 2020-2024, 2024-2030, 2020-2030
  • Table 5.4 Global Paediatric Vaccines Market: Revenue* ($m), AGR (%) and CAGR (%), 2018-2030
  • Table 5.5 Global Adult Vaccines Market Forecast: Revenues ($m) AGR (%), AGR (%), 2020-2030
  • Table 5.6 Global Influenza Vaccines Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 5.7 Global Therapeutic Vaccines Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 6.1 Global Vaccine Contract Manufacturing Market by Region: Revenue ($ m), 2018 and 2019
  • Table 6.2 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 6.3 Global Vaccine Contract Manufacturing Market by Region: CAGR (%), 2020- 2024, 2024-2030, 2020-2030
  • Table 6.4 Global Vaccine Contract Manufacturing Market by Region: Market Share (%), 2019, 2024, 2030
  • Table 7.1 North America Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 7.2 North America Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 7.3 North America Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 7.4 North America Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 7.5 North America Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 7.6 North America Vaccine Contract Manufacturing Market Forecast, By Class: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 7.7 U.S. Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 7.8 Canada Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 8.1 Europe Vaccine Contract Manufacturing Market by Country/Sub-region: Revenue ($ m) and Market Share (%), 2019
  • Table 8.2 Europe Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 8.3 Europe Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 8.4 Europe Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 8.5 Europe Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 8.6 Europe Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 8.7 Global Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 8.8 Global Vaccine Contract Manufacturing Market by Region: CAGR (%), 2020- 2024, 2024-2030, 2020-2030
  • Table 8.9 Germany Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 8.10 France Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 8.11 U.K. Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 8.12 Italy Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 8.13 Spain Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 8.14 Rest of Europe Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 9.1 Global Vaccine Contract Manufacturing Market by Country/Sub-region: Revenue ($ m) and Market Share (%), 2019
  • Table 9.2 Asia Pacific Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 9.3 Asia Pacific Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 9.4 Asia Pacific Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 9.5 Asia Pacific Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 9.6 Asia Pacific Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 9.7 Asia-Pacific Vaccine Contract Manufacturing Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2018-2030
  • Table 9.8 Japan Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 9.9 China Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 9.10 India Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 9.11 Rest of Asia Pacific Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 10.1 Latin America Vaccine Contract Manufacturing Market by Country/Sub-region: Revenue ($ m) and Market Share (%), 2019
  • Table 10.2 Latin America Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 10.3 Latin America Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 10.4 Latin America Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 10.5 Latin America Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 10.6 Latin America Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 10.7 Latin America Vaccine Contract Manufacturing Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2018-2030
  • Table 10.8 Brazil Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 10.9 Mexico Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 10.10 Rest of Latin America Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 11.1 Middle East & Africa Vaccine Contract Manufacturing Market by Country/Subregion: Revenue ($ m) and Market Share (%), 2018
  • Table 11.2 Middle East & Africa Vaccine Contract Manufacturing Market Forecast, By Vaccine Type: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 11.3 Middle East & Africa Vaccine Contract Manufacturing Market Forecast, By Workflow: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 11.4 Middle East & Africa Vaccine Contract Manufacturing Market Forecast, By Workflow (Downstream Processing): Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 11.5 Middle East & Africa Vaccine Contract Manufacturing (Upstream Processing) Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 11.6 Middle East & Africa Vaccine Contract Manufacturing Market Forecast, By Application: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 11.7 Middle East & Africa Vaccine Contract Manufacturing Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2018-2030
  • Table 11.8 Saudi Arabia Vaccine Contract Manufacturing Market Forecast, By Country: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 11.9 South Africa Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 11.10 Rest of Middle East & Africa Vaccine Contract Manufacturing Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2018-2030
  • Table 12.1. Lonza Group AG: Overview, 2020
  • Table 12.2 Lonza: Revenue ($m), AGR (%), 2015-2019
  • Table 12.3 Pfizer, Inc.: Overview, 2020
  • Table 12.4 Pfizer, Inc.: Revenue ($m), AGR (%), 2014-2018
  • Table 12.5 Merck & Co., Inc.: Overview, 2020
  • Table 12.6 Merck & Co, Inc.: Revenue ($m), AGR (%), 2015-2019
  • Table 12.7 AbbVie: Overview, 2020
  • Table 12.8 AbbVie: Revenue ($m), AGR (%), 2015-2019
  • Table 12.9. Baxter: Overview, 2020
  • Table 12.10 Baxter: Revenue ($m), AGR (%), 2014-2018
  • Table 12.11. Catalent, Inc.: Overview, 2020
  • Table 12.12 Catalent, Inc.: Revenue ($m), AGR (%), 2015-2019
  • Table 12.13. PRA Health Sciences, Inc.: Overview, 2020
  • Table 12.14 PRA Health Sciences, Inc.: Revenue ($m), AGR (%), 2015-2019
  • Table 12.15. KBI Biopharma, Inc.: Overview, 2020
  • Table 12.16. Charles River Laboratories.: Overview, 2020
  • Table 12.17 Charles River Laboratories: Revenue ($m), AGR (%), 2015-2019
  • Table 12.18. Boehringer Ingelheim: Overview, 2020
  • Table 12.19 Boehringer Ingelheim: Revenue ($m), AGR (%), 2014-2018
  • Table 12.20. IDT Biologika GmbH: Overview, 2020
  • Table 12.21. Meridian Life Science: Overview, 2020
  • Table 12.22 Meridian Life Science: Revenue ($m), AGR (%), 2015-2019
  • Table 13.1 SWOT Analysis of the Global Vaccine Contract Manufacturing Market, 2020- 2030
  • Figure 13.2 Vaccine Contract Manufacturing Market Drivers & Restraints 2020-2030
  • Table 14.1 Global Vaccine Contract Manufacturing Market Forecast: Revenue ($m), and CAGR (%), 2018, 2024 and 2030
  • Table 14.2 Global Vaccine Contract Manufacturing Market by Vaccine Type: CAGR (%), 2018, 2024, 2030
  • Table 14.3 Global Vaccine Contract Manufacturing Market by Region: CAGR (%), 2018, 2024, 2030

Companies Mentioned in This Report:

  • Sanofi S.A.
  • LONZA
  • Pfizer Inc.
  • Merck KGaA
  • Catalent, Inc.
  • AbbVie
  • Baxter BioPharma Solutions
  • GE Healthcare
  • Arabio
  • GSAL
  • GlaxoSmithKline
  • Avid Bioservices
  • Boehringer Ingelheim Biopharmaceuticals Gmbh
  • AMRI
  • ThermoVax
  • Roche
  • Novartis
  • AstraZeneca
  • BioKangtai
  • Beijing Tiantan Biological Products
  • PRA Health Sciences
  • KBI Biopharma
  • Charles River Laboratories
  • IDT Biologika GmbH
  • Meridian Life Science
  • Indapta Therapeutics
  • Allevi
  • DiNAQOR AG
  • Navrogen Inc.
  • BioNTech
  • Pfizer CentreOne
  • Anacor
  • Hospira
  • Gardasil
  • Galderma
  • Spirig Pharma
  • Baxter International Inc.
  • MaSTherCell
  • Zumutor Biologics, Inc.
  • Bristol-Myers Squibb
  • JSR Life Sciences
  • HemaCare Corporation
  • Bit Bio
  • Frost & Sullivan
  • GenePOC Inc.

Other Organisations Mentioned in This Report:

  • Biomedical Advanced Research and Development Authority (BARDA)
  • Center for Disease Control (CDC)
  • China Food and Drug Administration (CFDA)
  • Defense Advanced Research Projects Agency (DARPA)
  • Department of Health and Human Services (HHS)
  • Emory University
  • European Medical Agency
  • Food and Drug Administration (FDA)
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • PATH
  • U.S. Department of Health and Human Services Office
  • U.S. Department of Homeland Security
  • World Health Organisation (WHO)
  • Contract Pharma Outsourcing Survey
  • United Nations Children's Fund
  • World Health Assembly
  • Global Vaccine Action Plan
  • Gulf Cooperation Council Member States
  • Centers for Disease Control and Prevention
  • Government of Canada
目次
Product Code: PHA0735

The global vaccine contract manufacturing market was worth $2,241.6m in 2019 and is expected to grow at a CAGR of 9.3% from 2020-2025.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 290-page report you will receive 89 tables and 105 figures- all unavailable elsewhere.

The 290-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Revenue and growth forecasts from 2020 to 2030 for the global vaccine market

Revenue and growth forecasts from 2020 to 2030 for the global vaccine contract manufacturing market

Revenue and growth forecasts from 2020 to 2030 for the global vaccine contract manufacturing market by type:

  • Attenuated Vaccines
  • Inactivated Vaccines
  • Fluoroquinolones
  • Subunit Vaccines
  • Toxoid Vaccines

Revenue and growth forecasts from 2020 to 2030 for the global vaccine contract manufacturing market by workflow:

  • Downstream Processing: the revenues are further broken down into Fill & Finish Operations, Analytical & QC Studies, Packaging
  • Upstream Processing: the revenues are further broken down into Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

Revenue and growth forecasts from 2020 to 2030 for the leading regional and national markets:

  • North America: the revenues are further broken down into the US and Canada
  • Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain
  • Asia-Pacific: the revenues are further broken down into China, Japan, India and Rest of Asia-Pacific
  • Latin America: the revenues are further broken down into Brazil, Mexico, and Rest of Latin America
  • Middle East & Africa: the revenues are further broken into Saudi Arabia, South Africa and Rest of Middle East & Africa

The regional markets are further broken down by type and workflow.

Discussion and profiles of the leading players in the vaccine contract manufacturing market:

  • AbbVie
  • Baxter BioPharma Solutions
  • Boehringer Ingelheim
  • Catalent
  • Charles River Laboratories
  • IDT Biologika
  • Lonza
  • Meridan Lifescience
  • Pfizer
  • And many more

A SWOT analysis discussing the industry trends, strengths, weaknesses, opportunities and threats.

Discussion on vaccine manufacturing technologies covering new substrates for vaccine production, next-generation expression systems and vectors, equipment trends, pre-filled syringes and vaccines, lyophilization and vaccine manufacturing, cell-based techniques.

Key Questions Answered by this Report:

  • How is the vaccine contract manufacturing market evolving?
  • What is driving and restraining the vaccine contract manufacturing market?
  • What are the market shares of the leading segments of the vaccine contract manufacturing market in 2019?
  • What is the value of the leading sectors in important regions of the world?
  • What will be the main driver of the overall market from 2020 to 2030?
  • How will political and regulatory factors influence the regional markets and submarkets?
  • Will leading national vaccine contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the leading national markets change by 2030 and which country will lead the market in 2030?
  • How will the industry evolve during the period between 2020 and 2030?

Visiongain's study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.

Buy our report today Vaccine Contract Manufacturing Market Forecast 2020-2030: Prospects for Attenuated Vaccine, Inactivated Vaccine, Fluoroquinolones, Subunit Vaccines, Toxoid Vaccines. Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1. Report Overview
  • 1.1 Global Vaccine Contract Manufacturing Market Overview
  • 1.2 Overview of Findings
  • 1.3 Structure of the Report
  • 1.4 Global Vaccine Contract Manufacturing Market Segmentation
  • 1.5 Why You Should Read This Report
  • 1.6 How This Report Delivers
  • 1.7 Key Questions Answered by This Analytical Report
  • 1.8. Who is This Report For?
  • 1.9 Methodology
  • 1.10 Associated Visiongain Reports
  • 1.11 About Visiongain

2. Introduction to Vaccines

  • 2.1 The History of Vaccines
  • 2.2 How Do Vaccines Work?
  • 2.3 Types of Vaccine
    • 2.3.1 Attenuated Vaccine
    • 2.3.2 Inactivated Vaccine
    • 2.3.2 Inactivated Vaccine
    • 2.3.4. Subunit Vaccines
      • 2.3.4.1. Recombinant Subunit Vaccines
      • 2.3.4.1. Recombinant Subunit Vaccines
      • 2.3.4.1. Recombinant Subunit Vaccines
    • 2.3.7 Therapeutic Vaccines
  • 2.4 The Rise of the Vaccines Market
  • 2.5 Technological and Regulatory Improvements
  • 2.6 Vaccine Manufacturing Technologies
  • 2.7 New Substrates for Vaccine Production
    • 2.7.1 Shift towards Cell-Based Manufacturing Technology
    • 2.7.2 Benefits of Cell-Based Techniques
  • 2.8 Drivers
    • 2.8.1 Global increase in vaccination coverage
    • 2.8.2 Cost and time saving benefits offered by contract services
  • 2.9 Restraint
    • 2.9.1 Limited outsourcing by well-established vaccine manufacturers
    • 2.9.2. Other restrains

3. Vaccine Contract Manufacturing Market, 2020-2030

  • 3.1 The Global Vaccine Contract Manufacturing Market: Market Overview
  • 3.2 Outsourcing in the Pharmaceutical and Biotechnology Industry
  • 3.3 Global Vaccine Contract Manufacturing Market: Revenue Forecast 2020-2030
  • 3.4 Global Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
  • 3.5 Changing Market Shares by Segment 2020-2030
  • 3.6 Attenuated Vaccine: Revenue Forecast, 2018-2030
  • 3.7 Inactivated Vaccine: Revenue Forecast, 2018-2030
  • 3.8 Fluoroquinolones: Revenue Forecast 2018-2030
  • 3.9 Subunit Vaccines: Revenue Forecast 2018-2030
  • 3.10 Toxoid Vaccines: Revenue Forecast 2018-2030
  • 3.11 Others: Revenue Forecast 2018-2030

4. Vaccine Contract Manufacturing Market, by Workflow, 2020-2030

  • 4.1 The Global Vaccine Contract Manufacturing Market: Market Overview
  • 4.2 Global Vaccine Contract Manufacturing Market, By Workflow: Revenue Forecast 2020-2030
  • 4.3 Changing Market Shares by Segment 2020-2030
  • 4.4 Downstream Processing
    • 4.4.1 Fill & Finish Operations: Revenue Forecast 2018-2030
    • 4.4.2 Analytical & QC studies: Revenue Forecast, 2018-2030
    • 4.4.3 Packaging: Revenue Forecast 2018-2030
  • 4.5 Upstream Processing
    • 4.5.1 Mammalian Expression Systems: Revenue Forecast 2018-2030
    • 4.5.2 Bacterial Expression Systems: Revenue Forecast 2018-2030
    • 4.5.3 Yeast Expression Systems: Revenue Forecast 2018-2030
    • 4.5.4 Baculovirus/Insect Expression Systems: Revenue Forecast, 2018-2030
    • 4.5.6 Others: Revenue Forecast, 2018-2030

5. Vaccine Contract Manufacturing Market, By Application, 2020-2030

  • 5.1 The Global Vaccine Contract Manufacturing Market: Market Overview
  • 5.2 Global Vaccine Contract Manufacturing Market: Revenue Forecast 2020-2030
  • 5.3 Changing Market Shares by Segment 2020-2030
  • 5.4 Paediatric Vaccines: Revenue Forecast, 2018-2030
  • 5.5 Adult Vaccines: Revenue Forecast, 2018-2030
  • 5.6 Influenza Vaccines: Revenue Forecast, 2018-2030
  • 5.7 Therapeutic Vaccines: Revenue Forecast, 2018-2030

6. Leading National Markets 2020-2030

  • 6.1. Geographical Breakdown of the World Vaccine Contract Manufacturing Market
  • 6.2 World Vaccine Contract Manufacturing Market: Regional Forecast 2020-2030
    • 6.2.1 How Will Regional Market Shares Change to 2030?

7. North America Vaccine Contract Manufacturing Market 2020-2030

  • 7.1. North America Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030
  • 7.2. North America Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030
  • 7.3. US Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
  • 7.4. Canada Vaccine Contract Manufacturing Market: Trends and Developments

8. Europe Vaccine Contract Manufacturing Market 2020-2030

  • 8.1. Europe Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030
  • 8.2. Europe Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030
  • 8.3 Europe Markets: Changing Market Shares by Country, 2020-2030
  • 8.4. Germany Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
  • 8.5. France Vaccine Contract Manufacturing Market: Trends and Developments
  • 8.6. U.K. Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
  • 8.7. Italy Vaccine Contract Manufacturing Market: Trends and Developments
  • 8.8. Spain Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
  • 8.9. Rest of Europe Vaccine Contract Manufacturing Market: Market Forecast 2020-2030

9. Asia Pacific Vaccine Contract Manufacturing Market 2020-2030

  • 9.1. Asia Pacific Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030
  • 9.2. Asia Pacific Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030
  • 9.3. Japan Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
  • 9.4. China Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
  • 9.5. India Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
  • 9.6. Rest of Asia Pacific Vaccine Contract Manufacturing Market: Trends and Developments

10. Latin America Vaccine Contract Manufacturing Market 2020-2030

  • 10.1. Latin America Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030
  • 10.2. Latin America Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030
  • 10.3. Brazil Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
  • 10.4. Mexico Vaccine Contract Manufacturing Market: Trends and Developments
  • 10.5. Rest of Latin America Vaccine Contract Manufacturing Market: Trends and Developments

11. Middle East & Africa Vaccine Contract Manufacturing Market 2020-2030

  • 11.1. Middle East & Africa Vaccine Contract Manufacturing Market: Market Forecast, By Vaccine Type 2020-2030
  • 11.2. Middle East & Africa Vaccine Contract Manufacturing Market: Market Forecast, By Workflow 2020-2030
  • 11.3. Saudi Arabia Vaccine Contract Manufacturing Market: Market Forecast 2020-2030
  • 11.4. South Africa Vaccine Contract Manufacturing Market: Trends and Developments
  • 11.5. Rest of Middle East & Africa Vaccine Contract Manufacturing Market: Trends and Developments

12. Leading Companies in the Vaccine Contract Manufacturing Market, 2020

  • 12.1 LONZA
    • 12.1.1 Overview
    • 12.1.2 Lonza: Products and Services Offered
    • 12.1.3 Lonza: Financial Overview
    • 12.1.4 Recent Transactions Summary
  • 12.2 Pfizer, Inc.
    • 12.2.1 Overview
    • 12.2.2 Pfizer: Products and Services Offered
    • 12.2.3 Pfizer, Inc.: Financial Overview
    • 12.2.4 Recent Transactions Summary
  • 12.3 Merck & Co., Inc.
    • 12.3.1 Overview
    • 12.3.2 Merck & Co., Inc.: Products and Services Offered
    • 12.3.3 Merck & Co., Inc..: Financial Overview
    • 12.3.4 Recent Transactions Summary
  • 12.4 AbbVie
    • 12.4.1 Overview
    • 12.4.2 AbbVie: Vaccine Contract Manufacturing Product/Services Portfolio
    • 12.4.3 AbbVie: Financial Overview
    • 12.4.4 AbbVie: Recent Transactions Summary
  • 12.5 Baxter (Baxter BioPharma Solutions)
    • 12.5.1 Overview
    • 12.5.2 Baxter: Vaccine Contract Manufacturing Product/Services Portfolio
    • 12.5.3 Baxter: Financial Overview
    • 12.5.4 Recent Transactions Summary
  • 12.6 Catalent, Inc.
    • 12.6.1 Overview
    • 12.6.2 Catalent, Inc.: Vaccine Contract Manufacturing Product/Services Portfolio
    • 12.6.3 Catalent, Inc.: Financial Overview
    • 12.6.4 Recent Transactions Summary
  • 12.7 PRA Health Sciences
    • 12.7.1 Overview
    • 12.7.2 PRA Health Sciences, Inc.: Vaccine Contract Manufacturing Product/Services Portfolio
    • 12.7.3 PRA Health Sciences, Inc.: Financial Overview
    • 12.7.4 Recent Transactions Summary
  • 12.8 KBI Biopharma, Inc.
    • 12.8.1 Overview
    • 12.8.2 KBI Biopharma, Inc.: Vaccine Contract Manufacturing Product/Services Portfolio
    • 12.8.3 Recent Transactions Summary
  • 12.9 Charles River Laboratories
    • 12.9.1 Overview
    • 12.9.2 Charles River Laboratories: Vaccine Contract Manufacturing Product/Services Portfolio
    • 12.9.3 Charles River Laboratories: Financial Overview
    • 12.9.4 Recent Transactions Summary
  • 12.10 Boehringer Ingelheim
    • 12.10.1 Overview
    • 12.10.2 Boehringer Ingelheim: Vaccine Contract Manufacturing Product/Services Portfolio
    • 12.10.3 Boehringer Ingelheim: Financial Overview
    • 12.10.4 Recent Transactions Summary
  • 12.11 IDT Biologika GmbH
    • 12.11.1 Overview
    • 12.11.2 IDT Biologika GmbH: Vaccine Contract Manufacturing Product/Services Portfolio
    • 12.11.3 Recent Transactions Summary
  • 12.12 Meridian Life Science
    • 12.12.1 Overview
    • 12.12.2 Meridian Life Science: Vaccine Contract Manufacturing Product/Services Portfolio
    • 12.12.3 Meridian Life Science: Financial Overview
    • 12.12.4 Recent Transactions Summary

13. Qualitative Analysis of the Vaccine Contract Manufacturing Market, 2020-2030

  • 13.1. Vaccine Contract Manufacturing Industry Trends
  • 13.2 Strengths and Weaknesses of the Vaccine Contract Manufacturing Market, 2020
    • 13.2.1 Strengths
      • 13.2.1.1 Cost of in-house capabilities
      • 13.2.1.2 Outsourcing Improves Time to Market
      • 13.2.1.3 Manufacturers Get Access to Specialised Technologies
      • 13.2.1.3 Manufacturers Get Access to Specialised Technologies
    • 13.2.2 Weaknesses
      • 13.2.2.1 Mass Vaccine Manufacturing Kept In-house
      • 13.2.2.2. A Highly-Fragmented Vaccine Contract Manufacturing Market
    • 13.2.3. Opportunities
      • 13.2.3.1 Many Vaccines in the Product Pipeline
      • 13.2.3.2 Emerging Market's Growing Demand for Vaccines
      • 13.2.3.3 Dynamic Change: Emerging Markets are Major Vaccine Developers
      • 13.1.3.4. Changing World Demographics
    • 13.2.4. Threats
      • 13.2.4.1 Post Recession: Biotech Suffer from Severe Cuts in Capital Funding
      • 13.2.4.2 The Public are Slow to Accept Novel Technologies
      • 13.2.4.3 Perception of Risk by the Original Vaccine Manufacturers
  • 13.3 Vaccine Contract Manufacturing Drivers and Restraints, 2020-2030

14. Conclusions

  • 14.1 Overview of Current Market Conditions and Market Forecast, 2020-2030
  • 14.2 Attenuated Vaccine Will Remain the Dominant Vaccine Type
  • 14.3 Leading Regions in the Vaccine Contract Manufacturing Market in 2018
  • 14.4 Trends in the Vaccine Contract Manufacturing Market

Associated Visiongain Reports

  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain report evaluation form
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.